GHK-CU 50mg is suited to smaller-scale studies, pilot experiments, and preliminary research programmes
Reduce it
Browse all Peptides & GLP-1 education Related Reading Medical and Editorial Standards Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims
GLP-1s and Other Substance Use Disorders Beyond alcohol, researchers are beginning to examine whether GLP-1 receptor agonists may influence other substance use disorders
Statements Author contributions The author searched the available literature on the topic using PubMed, Embase, clincal.trials.gov and is the sole independent author of this manuscript and its content
UT Austin / MD Anderson Collaborative Research Summit, Austin, TX, 2022